Prevalence and clinical correlates of antinuclear antibody in patients with gastroparesis.
Henry P ParkmanMark L Van NattaAshima MakolMadhusudan GroverRichard W McCallumZubair MalikKennneth L KochIrene SarosiekBraden KuoRobert J ShulmanGianrico FarrugiaLaura MirielJames TonasciaFrank HamiltonPankaj J PasrichaThomas L Abellnull nullPublished in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2021)
The prevalence of a positive ANA in patients with gastroparesis was high at ~17% and did not differ significantly based on etiology. In idiopathic patients, ANA positivity was associated with rheumatoid arthritis, systemic sclerosis, and elevated ESR. ANA-positive gastroparesis represents a subset who often have other autoimmune symptoms or disorders, but less severe nausea and vomiting.
Keyphrases
- systemic sclerosis
- interstitial lung disease
- rheumatoid arthritis
- end stage renal disease
- risk factors
- newly diagnosed
- ejection fraction
- chronic kidney disease
- multiple sclerosis
- peritoneal dialysis
- prognostic factors
- early onset
- disease activity
- systemic lupus erythematosus
- drug induced
- depressive symptoms
- patient reported outcomes